Deep Intelligence Across Industries

Company Headquarters: Georgia, US Founded: 2009 Workforce: ~5,000 Company Working: Serta Simmons Bedding, LLC (SSB) develops and sells mattresses under the brand names Serta, Beautyrest, Tomorrow, and Tuft & Needle. It was initially known as Serta Simmons Holdings, LLC and changed its name to in 2014. The company operates in Georgia with additional locations in Connecticut, Texas, and California. It distributes mattresses through hospitality and independent retail channels throughout North America. It has more than 30 manufacturing plants throughout the US and Canada.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin;} Company Headquarters: Texas, US Founded: 1972 Workforce: ~5,000 Company Working: Epicor offers enterprise application software and services with a focus on small and mid-sized companies and divisions and subsidiaries of globally recognized 1000 enterprises. The company operates through three business segments — enterprise resource planning (ERP), retail solutions, and retail distribution. Epicor provides industry-specific solutions to the manufacturing, distribution, retail, services, and hospitality sectors. The company’s fully integrated systems primarily include licenses, professional services, support services, and hardware products, which are considered mission-critical to many of its customers. The company enables its customers to automate and integrate information and critical business processes throughout their enterprise, as well as across their supply chain and distribution networks; this lets the customers increase their productivity and efficiency, resulting in higher revenues, increased profitability, and improved working capital.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin;} Company Headquarters: Ontario, Canada Founded: 2003 Workforce: ~200 Company Working: FreshBooks provides cloud accounting solutions for small business owners. The company offers various solutions through its platforms such as online invoicing, expense tracking, time tracking, accounting reports & taxes, and bookkeeping. More than 24 million people have used its software to send, receive, print, and pay invoices; over USD 60 billion invoices are paid through FreshBooks, saving over an estimated 192 hours annually. The company has a customer base across over 120 countries. FreshBooks integrates with a number of applications to run the business with ease. FreshBooks also offers an easy-to-use transaction capture tool for small, service-based business clients.

Company Headquarters: North Carolina, US Founded: 1904 Workforce: ~245 Company Working: Kingsdown, Inc. (Kingsdown) designs and sells luxury mattresses through retailers in the US and internationally. It has manufacturing plants in California, Florida, Texas, and Virginia in the US, and in Australia, Brazil, China, the UK, Indonesia, Italy, Malaysia, Mexico, Taiwan, and the UAE. The company was formerly known as The Mebane Company and changed its name in March 1971. Kingsdown has operated as a subsidiary of Owen & Company Limited since 2018.

Company Headquarter: Milan, Italy Founded: 1994 Workforce: 3,450+ Company Working: Bracco Diagnostic Inc. (Bracco) is an international healthcare company, majorly focused on diagnostic imaging products. It has a wide portfolio consisting of over 1,800 patents. Its main products include contrast agents and medical substances used to improve the diagnostic accuracy of biomedical imaging. Its products are sold in over 100 countries, both directly and indirectly through branches, joint ventures, license, and distribution agreements. The company holds a leading position in important geographical areas such as Japan, North America, and Europe. Bracco’s production activities are carried out in Italy, Canada, Switzerland, Germany, Japan, and China.

Company Headquarters: California, US Founded: 2006 Workforce: 676 employees Company Working: The company was established in 2006 and is a global medical device company focused on providing innovative neuromodulation devices products for the treatment of chronic pain. The company has developed and commercialized the Senza spinal cord stimulation system for the treatment of chronic pain. The company has a presence in North America, Europe, and Australia.

Company Headquarters: Texas, US Founded: 2016 Company Working: Nuvectra Corporation offers its devices for neurological indications such as spinal cord stimulation. Moreover, the company is continuously engaged in improving and developing medical devices for neurological conditions, such as sacral nerve stimulation and deep brain stimulation.

Company Headquarters: California, US Founded: 2008 Company Working: The company designs, develops, and manufactures implantable devices for the treatment of neurological disorders. The company is continuously engaged in research and development of neurostimulation devices. The company is recognized for its innovation. It offers RNS System in the treatment of seizure.

Company Headquarters: Egypt Founded: 2012 Company Working: Clarus Company is an innovative dental company that specializes in cosmetic dental products. The company provides the latest technology in clear aligner treatments and manufacturing. Its products reduce the treatment time by 30% at a very economical price. Its standard clear aligners are made of traditional clear aligner sheets and are worn for seven days. Smart clear aligners are made of specially engineered clear aligner sheets. These are worn for 15 days. Smart clear aligners are 30% faster and require less time than any other aligner systems worldwide.

Company Headquarters: Georgia, US Founded: 2013 Workforce: ~400 Company Working: Arbor Pharmaceuticals, LLC (Arbor Pharmaceuticals) is a specialty pharmaceutical company based in the US that researches, develops, manufactures, and commercializes prescription products. The company operates through hospital & specialty, cardiology, neuroscience, pediatrics, and legacy & generics businesses. Gliadel is a registered trademark of Eisai Inc. and is manufactured by Eisai Inc., for Arbor Pharmaceuticals. The company markets various generic prescription products through its Wilshire division and has over a dozen abbreviated new drug applications (ANDAs) on file with the FDA and many others in different stages of development. The company produces novel chemical entities and previously approved molecules for new indications or in improved dosage forms.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Franklin Gothic Medium",sans-serif;} Oracle Corporation was established in 1977, with its headquarters in California, U.S. The company manufactures application software, hardware systems and provides solutions for other services. The company offers services in three major areas such as software as a service, platform as a service and infrastructure as a service. Under homomorphic encryption, the company provides IT infrastructure solutions such as data encryption. Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Franklin Gothic Medium",sans-serif;} The company has production centres, research and development engineers, personalization & data centres across the globe in regions such as U.S., India, Japan, U.K., Germany, New Zealand, Canada and Russia. The main strategy of the company is to invest more in research & development to innovate new products which can be offered through cloud and on premise software. It reported revenue of USD 37,047 million in FY2016.

SAP SE is the world's largest vendor of enterprise application software and the only Fortune-50-scale technology company headquartered in Europe. It sits at the transactional core of the global economy: its ERP systems record and execute the financial, procurement, supply-chain, manufacturing and human-capital processes of a large share of the world's biggest enterprises. The company is roughly four-fifths of the way through a decade-long conversion from a perpetual-licence, on-premise vendor to a cloud subscription business — cloud revenue reached €21.02bn in FY2025, 57% of total revenue, against €8.70bn and 32% in FY2021. That transition is now producing the operating leverage the equity story always promised: FY2025 non-IFRS operating margin of 28.3% and free cash flow of €8.24bn, nearly double the prior year. The strategic question for the next cycle is whether SAP can convert its unmatched process-and-data estate into a defensible position in agentic enterprise AI before hyperscalers, Oracle, Salesforce and AI-native challengers commoditize the application layer above it. --- ### What SAP does SAP develops, licenses, hosts, operates and supports enterprise application software, together with the data and AI platform layer beneath it and the professional services required to implement and run it. Its core product is enterprise resource planning (ERP) software — the system of record that governs a company's general ledger, financial close, procurement, inventory, production planning, order-to-cash, and workforce administration. Around that core SAP has assembled adjacent "line-of-business" suites for spend management (Ariba, Concur, Fieldglass), supply chain (Integrated Business Planning, Business Network), human capital (SuccessFactors), customer experience (Commerce, Sales, Service, Customer Data Cloud), and business transformation management (Signavio, LeanIX, WalkMe). In SAP's own framing from the FY2025 disclosures, the company describes itself as "a global leader in enterprise applications and business AI" that "stands at the nexus of business and technology," uniting "business-critical operations spanning finance, procurement, HR, supply chain, and customer experience." ### Independent characterization The more analytically useful description is that SAP operates three economically distinct businesses inside one P&L: 1. **A declining but extraordinarily profitable maintenance annuity.** Software support revenue of €10,525m in FY2025 (down 7% from €11,290m in FY2024) carries gross margins near 89%. This is the cash engine funding the transition. SAP has explicitly guided that the constant-currency decline rate of software support revenue will *accelerate* in coming years as customers migrate. 2. **A rapidly compounding cloud subscription business.** Cloud revenue of €21,023m in FY2025 (+23% reported, +26% constant currency), of which Cloud ERP Suite is €18,119m (+28%). Cloud gross margin reached 74.2% IFRS / 75.0% non-IFRS in FY2025, up 1.4pp / 1.7pp year over year — evidence that scale economics in SAP's hyperscaler-hosted delivery model are real. 3. **A low-margin services arm** (€4,262m, down 2% in FY2025) that exists largely to seed and de-risk cloud deals rather than to generate profit in its own right. SAP deliberately channels most implementation work to partners. ### Revenue model and mix *Zeros indicate line items not separately disclosed on a comparable continuing-operations basis in the FY2025 Five-Year Summary or FY2025 income statement; Cloud ERP Suite was first disclosed for FY2022. Source: SAP Integrated Report 2025, Consolidated Income Statements and Five-Year Summary.* The commercial model has four pricing constructs: (i) subscription per user/per module/per consumption metric for cloud; (ii) legacy perpetual licence plus ~19–22% annual maintenance for on-premise; (iii) time-based on-premise licences (recognized at a point in time, with associated support over time — combined with cloud into SAP's "subscription revenue" measure of €21,328m in FY2025, up 22%); and (iv) time-and-materials or fixed-fee professional services. Cross-cutting bundles — **RISE with SAP** (managed migration of existing ERP estates to private cloud) and **GROW with SAP** (greenfield public-cloud ERP for mid-market and new logos) — package software, infrastructure, tooling and services into a single contract. ### Value chain position and customers SAP occupies the application layer. It does not own its own hyperscale infrastructure at scale — it runs the substantial majority of its cloud estate on Amazon Web Services, Microsoft Azure and Google Cloud, supplemented by SAP-operated data centres for sovereign and regulated workloads (Delos Cloud in Germany, SAP NS2 in the United States, and the EU AI Cloud launched November 27, 2025). Downstream, implementation and change management are performed overwhelmingly by a partner ecosystem — Accenture, Deloitte, Capgemini, Infosys, TCS, Wipro, IBM, PwC, KPMG, EY, Tech Mahindra, Birlasoft and thousands of regional partners. Customer types skew heavily toward large enterprises and public-sector bodies. FY2025 and H1 2026 disclosed wins illustrate the profile: adidas, Bertelsmann, BioNTech, Daimler Truck, Deloitte, Électricité de France, H&M Group, HM Revenue & Customs, Jabil, Kirin Holdings, Nokia, Pirelli, RTX, Toyota, Weir Group, ACCIONA, Airbus, Electrolux, Eli Lilly, Gilead Sciences, Hindustan Zinc, Ørsted, Shell, Sun Pharma, Vonovia, Lockheed Martin, Rolls-Royce SMR, Mondelez International, Robert Bosch, Schaeffler, Zalando, Deutsche Bundesbank and Bank of Italy. Mid-market penetration runs through GROW with SAP and partner-led motions. End-markets served are effectively every asset-heavy and process-heavy industry: discrete and process manufacturing, automotive, aerospace and defence, chemicals, pharmaceuticals and life sciences, consumer products, retail, wholesale distribution, utilities and energy, oil and gas, mining, banking and insurance, telecommunications, transportation and logistics, professional services, healthcare, higher education and public sector.

Company Headquarters: Wilmington, NC Founded: 1985 Workforce: 21,000 Company Working: Pharmaceutical Product Development, LLC (PPD) is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. The firm’s clients and partners include pharmaceutical, biotechnology, medical device, and academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise, and to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.

Company Headquarters: Minneapolis, MN Founded: 1978 Workforce: 2500 Company Working: Pace Analytical Services, LLC (Pace) is an industry leader in sampling and analytical testing. The company provides analytical lab products for testing, staffing, and equipment with an extensive scope of services. Pace’s offers analytical testing and sampling for environmental, life sciences, GMP laboratory, and laboratory operations. The company has 32 environmental laboratories, six laboratory operation locations, four life sciences labs, and 48 service centers across the globe.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Million Oaks, California, US Founded: 1960 Workforce: ~10,850 Company Working: Teledyne Technologies Incorporated (Teledyne) offers enabling technologies for aerospace & defense, air and water quality environmental monitoring, factory automation, electronics design and development, deepwater oil & gas exploration and production, oceanographic research, and medical imaging and pharmaceutical research. The company operates through four business segments, namely, instrumentation, digital imaging, aerospace & defense, and engineered systems. Through its instrumentation segment, it offers test, measurement, and communication connectivity devices for marine, and environmental monitoring and control instruments. The digital imaging segment offers high-performance sensors and infrared and X-ray spectra used in industrial, camera, government, and medical applications. The aerospace & defense segment covers sophisticated electronic components, defense electronics, and aircraft information management systems, among others. It offers ROVs and AUVs through its subsidiary Teledyne Marine.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Port Coquitlam, Canada Founded: 1974 Workforce: ~50 Company Working: International Submarine Engineering Limited (ISE) is engaged in the designing, development, and integration of remotely operated vehicles (ROVs), AUVs, and robotic manipulator systems for land, subsea, and space training applications. It is an expert in submersible vehicles, robotics, and industrial automation systems. It offers subsea systems, teleoperated and autonomous robotic systems, manned submersible vehicles, unmanned surface vessels, manned submarines, and control systems. It also offers ROV components and spares, including thrusters, power packs, consoles, tether management systems, control rooms modules, and cables. The company further provides quality assurance, on-site training, local trials and testing, and support services. It serves petroleum, military, marine accident, telephone cable servicing, nuclear decontamination, subsea pipeline repair, hazardous waste handling, aircraft refueling, aircraft de-icing, and material handling industries.

### Positioning statement (150 words) Starbucks is the world's largest specialty coffee company and, by a wide margin, the dominant global operator of branded coffeehouses. It vertically integrates green-coffee sourcing, proprietary roasting and a 41,000-store retail estate spanning 89 markets, monetised through three channels: directly operated coffeehouses, a licensed store network run by regional partners, and a consumer-packaged-goods and foodservice franchise operated principally through the Global Coffee Alliance with Nestlé. The economic engine is North America, which generated 74% of fiscal 2025 revenue. Following two years of comparable-sales erosion, the company is executing a comprehensive operational reset — "Back to Starbucks" — under chairman and chief executive Brian Niccol, appointed September 2024. That reset has produced four consecutive quarters of comparable-sales growth through Q3 fiscal 2026 and two consecutive quarters of margin expansion, alongside a decisive shift in capital structure: the April 2026 divestiture of a controlling interest in Starbucks China converts the company's second-largest market to an asset-light licensing relationship. --- ### 2.1 The company's own characterisation In its fiscal 2025 Annual Report on Form 10-K, Starbucks describes itself as the premier roaster, marketer and retailer of specialty coffee worldwide, operating in 89 markets. It purchases and roasts high-quality coffees, which it sells alongside handcrafted coffee, tea and other beverages together with food through company-operated stores (which the company calls "coffeehouses"). It also sells coffee and tea products and licenses its trademarks through other channels — licensed stores, and grocery and foodservice via the Global Coffee Alliance with Nestlé S.A. Beyond the flagship Starbucks Coffee brand, the company markets goods and services under the Teavana, Ethos and Starbucks Reserve marks. The company states that its primary objective is to sustain Starbucks' standing as one of the most recognised and respected brands globally, and that continuous investment in brand and operations will deliver long-term revenue and income growth. That includes expanding the global store base in both mature markets such as the United States and higher-growth markets, and optimising the mix of company-operated and licensed stores. It emphasises beverage, equipment, process and technology innovation, including its digital platform. ### 2.2 Independent characterisation Starbucks is best understood as three economically distinct businesses sharing one brand and one supply chain: **(a) A capital-intensive, high-fixed-cost retail operator.** Company-operated stores generated 82.7% of fiscal 2025 net revenue ($30,744.8m of $37,184.4m). This business carries the full weight of store labour, occupancy and depreciation. In fiscal 2025 store operating expenses reached 55.5% of company-operated store revenue, up from 51.4% in fiscal 2024 — a 410-basis-point deterioration that is the single most important line item in understanding the fiscal 2025 profit collapse. Almost all of the 21,514 company-operated stores at fiscal 2025 year-end were leased, which is why operating lease liabilities of $10.5bn sit alongside $16.1bn of financial debt on the balance sheet. **(b) A royalty-and-wholesale licensing business.** Licensed stores produced 11.7% of fiscal 2025 revenue ($4,350.4m). Under this model Starbucks earns a margin on branded product and equipment sold to the licensee plus a royalty on the licensee's retail sales; the licensee bears operating costs and capital expenditure. Licensed stores carry lower gross margin but structurally higher operating margin than company-operated stores. This is the model Starbucks is now deliberately migrating toward: the April 2026 conversion of roughly 7,991 China company-operated stores to licensed status was the largest single such shift in the company's history. **(c) A consumer-packaged-goods and foodservice franchise.** "Other" revenue — 5.6% of fiscal 2025 revenue ($2,089.2m) — is recorded largely in Channel Development and comprises packaged coffee, tea and ready-to-drink sales outside the store estate plus Nestlé royalties. This is by far the highest-margin part of the enterprise: Channel Development operating margin was 47.3% in fiscal 2025 and 52.1% in Q3 fiscal 2026. It is also the least capital-intensive, since Nestlé controls distribution and, in some cases, roasting and packaging of Starbucks packaged products outside Starbucks stores. ### 2.3 Revenue model composition *(FY2024 and FY2025 from the Q4 FY2025 earnings release, 29 October 2025; FY2023 components derived from the FY2023 Form 10-K and shown as approximate.)* *(FY2025 Form 10-K, segment note.)* Within company-operated stores specifically, the retail sales mix in fiscal 2025 was 73% beverages, 23% food and 4% other, versus 74%/23%/3% in fiscal 2024 and 74%/22%/4% in fiscal 2023 (FY2025 Form 10-K). The food attach rate has been a deliberate management lever; Q3 fiscal 2026 ticket growth of 3.5% in North America was attributed in part to food attach and beverage modification. ### 2.4 Value chain position Starbucks occupies an unusually long stretch of the coffee value chain for a retailer. It controls substantially all green-coffee purchasing, roasting, packaging and global distribution for its own operations, operates ten farmer support centres (including one in Yunnan Province, China) staffed with agronomists, and owns most of its roasting plants while leasing the majority of warehousing and distribution facilities. Upstream, it does not own coffee farms at scale; it purchases from producers, trading companies and exporters using fixed-price and price-to-be-fixed commitments, hedged with forwards, futures and collars. Downstream in the CPG channel it has ceded distribution to Nestlé in exchange for an upfront payment and an ongoing royalty stream — an asset-light structure that materially improves returns but reduces control. ### 2.5 Customer types and end-markets - **Retail consumers** — the overwhelming majority of revenue, transacting in-store, via drive-thru, mobile order-and-pay, and third-party delivery. Starbucks Rewards had 34.2m 90-day-active U.S. members at fiscal 2025 year-end and 35.5m at January 2026, and the programme drove nearly 60% of U.S. company-operated revenue in fiscal 2025 (2026 Investor Day, 29 January 2026). - **Licensee operators** — regional master licensees and franchisees who buy product, equipment and supplies from Starbucks and remit royalties. Concentration among a small number of large regional licensees is explicitly flagged as a risk factor. - **Grocery, club and convenience retail** — served through Nestlé under the Global Coffee Alliance. - **Foodservice accounts** — offices, hotels, universities, hospitals, airlines and airports. - **Joint-venture partners** — the North American Coffee Partnership with PepsiCo for ready-to-drink, and from April 2026 the Boyu Capital joint venture in China in which Starbucks retains 40%. No single customer accounts for 10% or more of revenues (FY2025 Form 10-K). ---

Company Headquarters: Bromma, Sweden Founded: 2006 Company Working: Moberg Pharma AB develops patented topical pharmaceuticals for the treatment of common disorders through the use of innovative drug delivery. The company comprises only one area of operation, which is the development and commercialization of medical products. MOB-015 is the next generation of nail fungus treatment and BUPI is a new pain treatment for mouth and throat for cancer patients with oral mucositis. MOB-015 is currently undergoing two parallel phase 3 studies with expected topline results towards the end of 2019 and the second quarter of 2020, respectively. It has also signed two license agreements with leading players in Europe and Canada. It markets its products directly in the US, as well as through a network of distributors in approximately 40 countries.

Company Headquarters: US Founded:1977 Workforce: 200 Company Working: Toxikon is involved in preclinical contract research organization (CRO) for drug and medical device testing. Toxikon provides analytical, in-vivo, and in-vitro testing services for the pharmaceutical, biotechnology, and medical device industry. The services provided by the company include biocompatibility, surgical, ocular models, extractable and leachable (E&L), risk assessments, microbiology, toxicology, chemical characterization, impurities analysis, and synthesis and bioanalytical.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: La Garde, France Founded: 1936 Workforce: NA Company Working: The ECA Group operates as a subsidiary of the Gorgé Group. It is experienced in robotics, automation systems, simulation, and industrial processes. The ECA Group is also engaged in developing complete and innovative technological solutions for complex missions in hostile and confined environments. Through its robotics division, it provides AUVs for various applications such as pipeline inspection, platform surveillance, search and rescue, detection and classification, and intelligence. It serves its products and solutions for customers mainly operating in the defense, maritime, aerospace, simulation, energy, and industrial equipment.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Waltham, Massachusetts, US Founded: 1995 Workforce: ~100 Company Working: Boston Engineering Corporation delivers product designs and engineering consulting solutions. It offers products and solutions for industries such as medical devices, consumer products, defense & security, and industrial & commercial products. It has expertise in research and concept development, design for manufacturing, industrial design, software and GUI, motion control, wireless & IoT, and robotics. It is also one of the largest reseller partners of PTC Inc. (computer software and service company) in the Northeast US. It also offers sales and support, training, performance toolkits, and a system monitoring solution for PTC products.

Company Headquarters: Nottingham, Nottinghamshire, UK Founded: 1903 Workforce: 230 Company Working: Source BioScience is a healthcare and biotechnology company that operates businesses in three sectors, namely, healthcare, pharma biotech services, and life science research. The company is engaged in providing diagnostic and screening services to the healthcare sector as well as genetic analyses and biomolecular tools and products to the life science research and pharma biotech sectors. The services offered by Source BioScience in the health care sector comprises screening and reference laboratory diagnostic testing services for cancer and other diseases; whereas for pharma-biotech it offers a range of services from clinical trials, tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination, and assay development to pharmacogenomics including genotyping and gene expression analysis.

Company Headquarters: US Founded: 1982 Workforce: 10,001+ Company Working: WuXi AppTec’s laboratory testing division is a comprehensive and integrated testing platform for drug and medical device development. Fully integrated within WuXi AppTec, the laboratory testing division provides in-vivo and in-vitro assays from early screening through clinical sample analysis and medical device testing from development through product lifecycle management. It operates with full transparency, providing the high-quality data needed to advance the project while meeting international standards for regulatory compliance and maintaining industry-leading turnaround times. The laboratory testing division consists of three integrated testing platforms, namely, WuXi AppTec IND (WIND) for preclinical drug development, clinical drug development, and medical device testing. Each platform is supported by the complementary capabilities of four service units, which include analytical, bioanalytical, toxicology, and DMPK services. Testing services are offered as a comprehensive package in support of global IND/NDA filings, or on a standalone basis, with customized study designs available to meet the varying needs of the diverse client base.

Company Headquarters: London, UK Founded: 2006 Workforce: ~50-200 Company Working: CENTOGENE AG (CENTOGENE) is a leading genetic biotech company that offers biochemical diagnostic tests, genetic diagnostic tests, next-generation sequencing, and biomarkers used for the diagnosis of rare hereditary disorders. CENTOGENE supports clinicians with genetic counseling services, as well as performs analysis of biomarkers for lysosomal storage disorders. The company also provides Extan kits for various genetic diseases, such as Ehlers-Danlos syndrome, Charcot-Marie-Tooth disease, spastic paraplegia, dystonia, osteogenesis imperfecta, and Alpers syndrome.

Company Headquarters: Concord, US Founded: 2007 Workforce: ~50 Company Working: Valerion Therapeutics (Valerion) a part of the Alopexx Enterprises, is an emerging biotech company, involved in developing product category for rare diseases. Valerion develops chemical conjugation products by utilizing enzymes, proteins, oligonucleotides, and more; to treat several diseases with limited or no current therapeutic options.

Company Headquarters: California, US Founded: 2007 Workforce: 200 Company Working: OKYALO is a manufacturer and exporter of aloe vera products and serving the customers worldwide for 11 years. The company’s product line includes aloe vera drinks, aloe vera pulp, aloe vera gel juice, and aloe vera powder. It supplies its products across the globe and majorly serves the cosmetic industry. The company has an aloe vera farm in the US.

Company Headquarters: Fredericksburg, US Founded: 1984 Workforce: 100 Company Working: Biogenic Foods (Biogenic) is a provider of natural ingredients and the company’s product line includes herb & plant bulk extracts and powders, liquids & oil extracts, specialty blended products, vitamins & minerals, and nutraceuticals. The company also offers natural sweeteners and drink blends. Biogenic sells its products to individual customers as well as several industries.

Company Headquarters: Shaanxi, China Founded: 2015 Workforce: 100 Company Working: Shaanxi Bolin Biotechnology Co., Ltd (Shaanxi) is a producer of healthcare ingredients. The company offers herbal extract, fruit and vege powder, cosmetic ingredients, plant oil, natural colors, enzymes, amino acid, protein powders, and vitamins. It has a manufacturing plant in China. The company’s production base covers 1,500 square meters, which is fully equipped with sus304 stainless steel extraction tanks, vacuum concentration tanks, water-sediment tanks, crystal tanks, chromatography columns, high-speed tube filters, vacuum drying oven, and spray drying towers.